Detalhe da pesquisa
1.
Revealing and harnessing CD39 for the treatment of colorectal cancer and liver metastases by engineered T cells.
Gut
; 72(10): 1887-1903, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37399271
2.
Flow cytometry data mining by cytoChain identifies determinants of exhaustion and stemness in TCR-engineered T cells.
Eur J Immunol
; 51(8): 1992-2005, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34081326
3.
Invariant NKT cells contribute to chronic lymphocytic leukemia surveillance and prognosis.
Blood
; 129(26): 3440-3451, 2017 06 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-28465341
4.
Invariant NKT cell reconstitution in pediatric leukemia patients given HLA-haploidentical stem cell transplantation defines distinct CD4+ and CD4- subset dynamics and correlates with remission state.
J Immunol
; 186(7): 4490-9, 2011 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-21357532
5.
High-frequency and adaptive-like dynamics of human CD1 self-reactive T cells.
Eur J Immunol
; 41(3): 602-10, 2011 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-21246542
6.
TCR-engineered iNKT cells induce robust antitumor response by dual targeting cancer and suppressive myeloid cells.
Sci Immunol
; 7(74): eabn6563, 2022 08 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35984893
7.
Workflow for high-dimensional flow cytometry analysis of T cells from tumor metastases.
Life Sci Alliance
; 5(10)2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35724271
8.
On the use of donor-derived iNKT cells for adoptive immunotherapy to prevent leukemia recurrence in pediatric recipients of HLA haploidentical HSCT for hematological malignancies.
Clin Immunol
; 140(2): 152-9, 2011 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-21185785
9.
Dicer-dependent microRNA pathway controls invariant NKT cell development.
J Immunol
; 183(4): 2506-12, 2009 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-19625646
10.
Human T cells engineered with a leukemia lipid-specific TCR enables donor-unrestricted recognition of CD1c-expressing leukemia.
Nat Commun
; 12(1): 4844, 2021 08 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34381053
11.
CD1d-restricted help to B cells by human invariant natural killer T lymphocytes.
J Exp Med
; 197(8): 1051-7, 2003 Apr 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-12695492
12.
Expression of functional GPR35 in human iNKT cells.
Biochem Biophys Res Commun
; 398(3): 420-5, 2010 Jul 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-20599711
13.
A retinoic acid-dependent stroma-leukemia crosstalk promotes chronic lymphocytic leukemia progression.
Nat Commun
; 9(1): 1787, 2018 05 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29725010
14.
Harnessing the CD1 restricted T cell response for leukemia adoptive immunotherapy.
Cytokine Growth Factor Rev
; 36: 117-123, 2017 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28712863
15.
Targeting leukemia by CD1c-restricted T cells specific for a novel lipid antigen.
Oncoimmunology
; 4(3): e970463, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25949888
16.
A novel self-lipid antigen targets human T cells against CD1c(+) leukemias.
J Exp Med
; 211(7): 1363-77, 2014 Jun 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-24935257
17.
Invariant natural killer T cells reconstitution and the control of leukemia relapse in pediatric haploidentical hematopoietic stem cell transplantation.
Oncoimmunology
; 1(3): 355-357, 2012 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22737613
18.
Innate-like effector differentiation of human invariant NKT cells driven by IL-7.
J Immunol
; 180(7): 4415-24, 2008 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-18354162
19.
CD4 engagement by CD1d potentiates activation of CD4+ invariant NKT cells.
Blood
; 110(1): 251-8, 2007 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17363727
20.
Innate immune responses support adaptive immunity: NKT cells induce B cell activation.
Vaccine
; 21 Suppl 2: S48-54, 2003 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-12763683